Similac NEC Settlement Talks Advance as Court Orders Claim Census
The federal judge overseeing lawsuits involving premature infants who developed necrotizing enterocolitis (NEC) after being fed Similac has ordered a comprehensive census of both filed and unfiled claims. This data collection aims to give all parties a clearer picture of the litigation’s scope as settlement negotiations continue. The move could help streamline talks and ensure that any resolution addresses both active lawsuits and potential future claims.
https://www.aboutlawsuits.com/similac-nec-settlement-talks-mdl-census-order-filed-unfiled-claims/
Thousands of NEC Baby Formula Cases to Stay in State Courts
An appellate court has ruled that thousands of NEC baby formula lawsuits will remain in the state courts where they were originally filed, rejecting efforts to move them into a consolidated federal proceeding. Plaintiffs argue that keeping the cases local allows for faster trials and better reflects the experiences of affected families. The ruling represents a setback for formula manufacturers seeking centralized control over the litigation.
Pfizer Faces Growing Depo-Provera Litigation Over Brain Tumor Risk
Litigation against Pfizer over its Depo-Provera contraceptive injection continues to grow after two studies found that users may face up to 35 times higher risk of developing meningioma brain tumors compared to those using other birth control methods. Plaintiffs claim Pfizer failed to adequately warn women of these serious risks. The lawsuits are being filed in both state and federal courts, and more claims are expected as awareness spreads.
Settlement Nears in Paraquat Parkinson’s Lawsuits
The federal judge presiding over the Paraquat multidistrict litigation (MDL) has extended certain case deadlines to allow the parties more time to finalize settlement details. Thousands of farmers and agricultural workers allege that exposure to the herbicide caused Parkinson’s disease. The extensions are viewed as a sign that a nationwide settlement could soon be announced, potentially ending years of contentious litigation.
Syngenta Settlement Talks Move Forward in Paraquat Litigation
Separate reports confirm that settlement negotiations between Syngenta and plaintiffs in Paraquat lawsuits are progressing toward resolution. While no official agreement has been disclosed, insiders indicate that the discussions are advanced. Any settlement could provide substantial compensation to those diagnosed with Parkinson’s after years of working with the herbicide.
https://www.thenewlede.org/2025/08/syngenta-closer-to-settling-paraquat-lawsuits/
Bayer Adds $13.7B to Roundup Reserves Amid Ongoing Cancer Claims
Bayer has increased its litigation reserves by $13.7 billion to address the mounting number of lawsuits linking Roundup to non-Hodgkin’s lymphoma. The company is also raising its 2025 sales forecast, signaling confidence in its core business despite ongoing legal troubles. Thousands of cases remain unresolved, with many plaintiffs rejecting earlier settlement offers.
https://www.thenewlede.org/2025/08/syngenta-closer-to-settling-paraquat-lawsuits/
Roundup Cancer Lawsuit Sent Back to State Court
A non-Hodgkin’s lymphoma lawsuit involving Roundup has been remanded to state court after a federal judge declined jurisdiction. This decision clears the way for a local jury trial, which could serve as an important test for similar cases. State-level trials often move more quickly and can produce significant verdicts that influence settlement talks.
https://www.aboutlawsuits.com/roundup-non-hodgkins-lymphoma-lawsuit-remanded/
J&J Hit with $42M Verdict in Talc Cancer Case
A Massachusetts jury awarded $42 million to a man who claimed that decades of using Johnson & Johnson’s talcum powder caused his cancer. The verdict adds to a series of costly defeats for J&J in talc litigation. The company maintains its products are safe and has vowed to appeal the decision.
Plaintiffs Reject J&J’s $8B Talc Settlement Proposal
Plaintiffs in the nationwide talcum powder litigation have rejected Johnson & Johnson’s proposed $8 billion settlement. Attorneys say the offer undervalues claims, particularly those involving ovarian cancer and mesothelioma. The rejection means litigation will continue, with trials set in multiple jurisdictions.
Women’s Voices to Shape Future Talc Settlements
A newly announced structure in talc litigation leadership will ensure that female plaintiffs have a direct voice in settlement negotiations. Advocates say this representation is critical given the large number of ovarian cancer claims. The move could influence how future mass torts incorporate diverse perspectives in resolution talks.
https://www.aboutlawsuits.com/women-will-have-voice-settlement-talcum-powder-lawsuits/
Christopher Seeger Named Lead Settlement Negotiator
Renowned trial lawyer Christopher Seeger has been appointed to lead settlement discussions in the talcum powder MDL. Seeger has been involved in major mass tort settlements and is expected to play a key role in bridging the gap between plaintiffs and J&J. His appointment could signal renewed momentum toward a global resolution.
Former Judge to Reassess Talc Expert Evidence
Retired federal judge Freda Wolfson has been appointed as special master to review expert evidence in the federal talc litigation. The review could determine whether cases proceed to trial or are dismissed. While she now works at a law firm that represents J&J in other matters, the court found no conflict due to internal safeguards.
https://www.insurancejournal.com/news/national/2025/08/08/834978.htm
Craig H. Alinder, Vice President
Office: 802-664-4201 | Email: craig@legalcalls.com
LegalCalls.com | Calendly | Download our most recent price sheet
Legal Calls, 2108 N Street, Suite 4809, Sacramento, CA 95816, (877) 853-5801
Legal Calls
2108 N Street, Suite 4809
Sacramento, CA 95816
8AM – 8PM PST Mon. – Fri.
Sat. – Sun. Closed
Copyright © 2025 Clear View Enterprises LLC